Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00295009
Other study ID # PDL-07272001
Secondary ID
Status Completed
Phase N/A
First received February 20, 2006
Last updated July 31, 2014
Start date September 2001
Est. completion date April 2011

Study information

Verified date July 2014
Source Synthes USA HQ, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The objective of this clinical investigation is to compare the safety and effectiveness of ProDisc total disc replacement to spinal fusion surgery in the treatment of discogenic pain associated with DDD in the lumbosacral spine. There will be separate study arms for one and two level cases.


Recruitment information / eligibility

Status Completed
Enrollment 852
Est. completion date April 2011
Est. primary completion date April 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Degenerative Disc Disease (DDD) in one or two adjacent vertebral levels between L3 and S1. Diagnosis of DDD requires: a)Back and/or leg (radicular) pain; and b)Radiographic confirmation of any 1 of the following by CT, MRI, discography, plain film, myelography and/or flexion/extension films: Instability (greater than or equal to 3mm translation or 5° angulation); Decreased disc height >2mm; Scarring/thickening of annulus fibrosis; Herniated nucleus pulposus; or Vacuum phenomenon.

- Age between 18 and 60 years.

- Failed at least 6 months of conservative treatment.

- Oswestry Low Back Pain Disability Questionnaire score of at least 20/50 (40%)(Interpreted as moderate/severe disability).

- Psychosocially, mentally and physically able to fully comply with this protocol including adhering to follow-up schedule and requirements and filling out forms.

- Signed informed consent.

Exclusion Criteria:

- No more than 2 vertebral levels may have DDD and all diseased levels, either one or two, must be treated.

- Patients with involved vertebral endplates dimensionally smaller than 34.5mm in the medial-lateral and/or 27mm in the anterior-posterior directions.

- Known allergy to titanium, polyethylene, cobalt, chromium, or molybdenum.

- Prior fusion surgery at any vertebral level.

- Clinically compromised vertebral bodies at the affected level(s) due to current or past trauma.

- Radiographic confirmation of facet joint disease or degeneration.

- Lytic spondylolisthesis or spinal stenosis.

- Degenerative spondylolisthesis of grade >1.

- Back or leg pain of unknown etiology.

- Osteopenia or Osteoporosis: A screening questionnaire for osteoporosis, SCORE (Simple Calculated Osteoporosis Risk Estimation), will be used to screen patients to determine if a DEXA scan is required. If DEXA is required, exclusion will be defined as a DEXA bone density measured T score less than

- 1.0. The World Health Organization defines osteoporosis as a DEXA T score less than or equal to -2.5.

- Paget's disease, osteomalacia or any other metabolic bone disease (excluding osteoporosis which is addressed above).

- Morbid obesity defined as a body mass index >40 or a weight more than 100 lbs. over ideal body weight.

- Pregnant or interested in becoming pregnant in the next 3 years.

- Active infection - systemic or local.

- Taking medication or any drug known to potentially interfere with bone/soft tissue healing (e.g., steroids).

- Rheumatoid arthritis or other autoimmune disease.

- Systemic disease including AIDS, HIV, Hepatitis.

- Active malignancy: A patient with a history of any invasive malignancy (except non-melanoma skin cancer), unless he/she has been treated with curative intent and there has been no clinical signs or symptoms of the malignancy for at least 5 years.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
ProDisc
Total disc replacement with ProDisc
Procedure:
Spinal Fusion
A circumferential fusion will be utilized as the control group in this study. The technique will consist of an interbody fusion procedure using commercially available femoral ring allograft. A posterior lateral fusion with autogenous iliac crest bone graft, combined with pedicle screw instrumentation.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Synthes USA HQ, Inc.

Outcome

Type Measure Description Time frame Safety issue
Primary Overall Success Overall success was a composite endpoint.
A ProDisc patient was considered an overall success if, and only if, ALL of the following criteria were met:
ODI score improved by at least 15% from baseline;
SF-36 score improved from baseline;
Neurologic parameters maintained or improved from baseline;
No re-operations to modify or remove the implant; and
Independent radiographic review confirmed no migration/subsidence, radiolucency, loss of disc height, loss of range of motion, or boney fusion.
A Fusion patient was a considered to be a success if, and only if, ALL of the following criteria were met:
Same as above
Same as above
Same as above
No re-operations to modify the fusion site or correct a complication with an implant; and
Independent radiographic review confirmed strong evidence of fusion and no motion, visible gaps in fusion mass, loss of disc height, migration/subsidence, implant loosening, halos, or radiolucencies
24 Months No
Primary Overall Success Overall success was a composite endpoint. A ProDisc patient was considered an overall success if, and only if, ALL of the following criteria were met:
ODI score improved by at least 15% from baseline;
SF-36 score improved from baseline;
Neurologic parameters maintained or improved from baseline;
No re-operations required to modify or remove the implant; and
Independent radiographic review confirmed no migration/subsidence, radiolucency, loss of disc height, loss of range of motion, or boney fusion.
A Fusion patient was a considered to be a success if, and only if, ALL of the following criteria were met:
Items numbered 1-3, above; 4. No re-operations required to modify the fusion site or correct a complication with an implant; and 5. Independent radiographic review confirmed strong evidence of fusion and no motion, visible gaps in fusion mass, loss of disc height, migration/subsidence, implant loosening, halos, or radiolucencies
60 Months No
See also
  Status Clinical Trial Phase
Recruiting NCT05484557 - Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury N/A
Not yet recruiting NCT02535273 - The Effect of Dexmedetomidine Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia Phase 4
Recruiting NCT02187653 - Intraoperative Monitoring (IOM) Patient Registry N/A
Completed NCT03832036 - The Diagnostic and Prognostic Value of Two Quantitative Clinical Tests in Patients With Lumbar Disc Herniation N/A
Completed NCT03015142 - Observational Clinical Study to Plan, Position and Check Instrument Placement for Spine Surgery Interventions
Not yet recruiting NCT06123624 - Desflurane and Sevoflurane on Remifentanil Requirement N/A
Completed NCT03158766 - Subclinical Propionibacterium Acnes Infection Estimation in the Intervertebral Disc (SPInE-ID)
Not yet recruiting NCT02416557 - Effect of PEEP on Intraoperative Hypothermia N/A
Completed NCT02724111 - Effect of Neuromuscular Blockade on Operating Conditions and Overall Satisfaction During Spinal Surgery Phase 4
Enrolling by invitation NCT03492372 - Molecular Characterization of Spinal Tissue
Completed NCT03753945 - Spine MRI in Patients With Deep Brain Stimulation (DBS) N/A
Terminated NCT03802656 - Vertebral Body Tethering Treatment for Idiopathic Scoliosis N/A
Recruiting NCT02809781 - A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis Phase 2/Phase 3
Not yet recruiting NCT02762656 - The Effect of Perioperative Lidocaine Intravenous Infusion on Postoperative Recovery After Spine Surgery. Phase 4
Completed NCT00756301 - Cutaneous Administration of Local Anesthetic for Spine Injection Procedures N/A
Completed NCT00808665 - Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion Phase 4
Completed NCT03562455 - Virtual Reality for Power Wheelchair Training N/A
Completed NCT00979108 - The Value of Traction in the Treatment of Cervical Radiculopathy Phase 3
Completed NCT00942227 - The Value of Traction in Treatment of Lumbar Radiculopathy Phase 3
Completed NCT01020929 - Incidence of Simultaneous Epidural and Intravascular Injection N/A